Jim Kramer’s Update on Bullpen Stocks
On Wednesday, Jim Kramer shared insights regarding all ten stocks on his bullpen watch list. During the Investing Club’s June meeting, he was particularly enthusiastic about two new additions.
Boeing: Jim hasn’t added Boeing to his club portfolio just yet, aiming to clear space first. Generally, new additions wait for an existing stock to be sold off. He was excited to mention that Boeing shares were around $200 each as of Wednesday afternoon, with hopes to “buy here.” Nonetheless, he is uncertain about the future performance of current holdings like Salesforce and Bristol Myers and is considering potential removals. He sees Boeing as a likely beneficiary from increased aircraft sales tied to international trade.
Cisco Systems: Jim appreciates Cisco, especially given its progress with artificial intelligence and enhanced cybersecurity offerings. However, he’s hesitant to invest right now for a couple of reasons. First, shares are currently at $68, recently hitting a new 52-week high. He hopes to purchase at a lower price. Second, similar to Boeing, he feels the need to sell off another stock first.
Airbnb: Jim finds Airbnb interesting as it’s changing the accommodation landscape with peer-to-peer rentals. But he feels it’s a “no go” for investment now due to their weaker recent revenue. Management’s guidance doesn’t look promising, compounded by concerns about a slowdown in U.S. travel.
Dell Technologies: Known for its personal computers, Dell is a major player in the AI sector. Jim expressed some frustration for missing out on its surge, which has exceeded 80% since hitting a low of $66 in April. As of Wednesday, shares were trading at $120.
Intuitive Surgical: This Medtech company is noted for its leadership in robot-assisted surgery. Jim took note of the risks here, particularly tariffs, as much of their equipment is produced in Mexico.
Marvell Technology: A standout name in custom chips, Marvell has seen a substantial rebound from a low of $47 in April, with shares trading at $75. Jim thinks they may have missed the boat on Marvell, but feels satisfied holding two chip stocks, Nvidia and Broadcom, the latter outperforming Marvell this year.
Novartis: The Swiss pharmaceutical giant stands out for its strong product pipeline. However, since they already hold Bristol Myers, Novartis remains on the sidelines for now.
Nucor: Jim sees Nucor as a leading steel manufacturer. While tariffs on imported steel could increase costs, he believes the stock is “ultimately right” considering the shortage of domestic steel options, especially given the protective stance taken by President Trump. Nucor recently reported solid reserve results for the second quarter.
Raytheon: Jim supports this defense contractor, although stock prices reached $149 on June 18, which raised some eyebrows.
Sempra: Jim finds Sempra, diversified in utilities and energy infrastructure, to be intriguing but noted that their recent quarterly performance was “not enough.” The company is also dealing with various regulatory hurdles. They don’t currently own any utility stocks but are evaluating Sempra for potential diversification.
As part of the CNBC Investment Club, members receive a trade warning before Jim executes any transactions. After sending out a trade alert, Jim waits 45 minutes before making moves in the Charitable Trust portfolio. If mentioned on CNBC, he’ll wait 72 hours before executing the trade.
This information comes with our Terms of Use and Privacy Policy, emphasizing that there are no guaranteed outcomes or promises regarding investments.
